Dual effects of ARX poly-alanine mutations in human cortical and interneuron development

Insights

Mutations in the Aristaless-related homeobox (ARX) gene cause infantile spasms. Human brain organoid models reveal ARX mutations disrupt neuronal development and migration, offering new therapeutic targets for this devastating childhood epilepsy.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Genetics

Background:

  • Infantile spasms are a severe childhood epilepsy linked to intellectual disability.
  • Mutations in the Aristaless-related homeobox (ARX) gene are found in approximately 5% of affected males.
  • Existing animal models do not fully replicate human infantile spasms, highlighting the need for human-specific models.

Purpose of the Study:

  • To investigate the impact of Aristaless-related homeobox (ARX) gene mutations, specifically the PAE mutation, on human brain development using organoid models.
  • To understand the cellular and molecular mechanisms underlying ARX-related infantile spasms and developmental epilepsies.

Main Methods:

  • Utilized human cortical organoids (COs) and ganglionic eminence organoids (GEOs) to model cortical and interneuron development.
  • Analyzed the effects of ARX PAE mutations on gene expression, cell migration, and cell proliferation in organoid models.
  • Investigated potential therapeutic interventions by inhibiting CXCR4 to rescue observed migration defects.

Main Results:

  • ARX PAE mutations led to decreased ARX expression and enhanced interneuron migration in GEOs, a phenotype reversible by CXCR4 inhibition.
  • Observed an initial increase in radial glia and intermediate progenitor cells, followed by a loss of cortical neurons in organoid models.
  • Found ARX upregulation and altered CDKN1C expression in patient-derived COs, with ARX PAE assembloids exhibiting early hyperactivity.

Conclusions:

  • Human brain organoid models effectively recapitulate key aspects of ARX-related infantile spasms and developmental epilepsies.
  • ARX PAE mutations disrupt crucial developmental processes, including interneuron migration and neuronal cell populations.
  • Targeting ARX PAE pathways in human organoids provides a promising avenue for developing novel therapeutic strategies for infantile spasms.